Rare Disease Day: Pharma's role in raising awareness

In healthcare, numbers often dominate discussions. Healthcare systems and policymakers use prevalence and incidence rates to allocate resources, ensuring that facilities, personnel, and funds are directed effectively. This logic does not apply to the world of rare diseases, which are characterized by their low patient numbers. A disease is defined as rare if it affects fewer than 1 in 2,000 people in Europe, or fewer than 200,000 people in the US (1 in 1,500 people).

However, when these many individual diseases are brought together, the numbers become much alarming: There are 300 million people worldwide living with a rare disease.

For pharmaceutical companies, Rare Disease Day offers more than just symbolic significance. It is an opportunity to raise awareness and connect with patients and their caregivers, building a bridge between the…